ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Ambulatory Health Care Facilities, Medical Specialty

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,134Medicare Part D Prescriptions Filled, Including Refills
$558K Total Retail Price of All Prescriptions
398 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 480 395
SIMVASTATIN 365 290
HYDROCODONE-ACETAMINOPHEN 340 237 S3
LEVOTHYROXINE SODIUM 287 270
FUROSEMIDE 279 245
OMEPRAZOLE 255 199
METOPROLOL SUCCINATE 223 202
METFORMIN HCL 215 170
HYDROCHLOROTHIAZIDE 213 157
GABAPENTIN 188 98
AMLODIPINE BESYLATE 184 170
CITALOPRAM HBR 174 130
ATORVASTATIN CALCIUM 168 157
ATENOLOL 167 131
WARFARIN SODIUM 161 156
METOPROLOL TARTRATE 149 116
LOSARTAN POTASSIUM 128 123
MORPHINE SULFATE ER 115 50 S2
TAMSULOSIN HCL 113 100
OXYCODONE HCL 109 53 S2
POTASSIUM CHLORIDE 105 93
LOVASTATIN 102 98
CARVEDILOL 100 81
DIGOXIN 98 96
FLUOXETINE HCL 91 63
NAMENDA 90 90
TRAZODONE HCL 84 69
BACLOFEN 83 58
TRIAMCINOLONE ACETONIDE 81 74
PROAIR HFA 81 68
ALLOPURINOL 77 77
PRAVASTATIN SODIUM 75 63
MELOXICAM 74 39
METHADONE HCL 70 16 S2
DONEPEZIL HCL 69 69
RANITIDINE HCL 67 44
PROCHLORPERAZINE MALEATE 66 37
ALENDRONATE SODIUM 65 47
CLOPIDOGREL 64 56
GLIMEPIRIDE 64 52
CRESTOR 60 56
SPIRIVA 59 59
TRAMADOL HCL 57 37
CYCLOBENZAPRINE HCL 54 32 R
SERTRALINE HCL 53 41
CLONIDINE HCL 53 35
LIDODERM 50 32
AVODART 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.